Moreover, the study provided evidence that PDK4 is significantly overexpressed in LDL-exposed CD14+ monocytes indicating its potential role in the aberrant activation of CD14+ monocytes, which may be implicated in the pathogenesis of CAD. Here, PDK4 is linked to coronary artery disorder.